[1]. The Impact of Secondary Malignancies After Autologous Stem Cell Transplantation in Multiple Myeloma 
 血液内科   (有)科学評論社   [Volume]88 [Issue]4 [Page]395 -395-400  (2024/)   [Reviewed] No   
[2]. Effect of Early Nutritional Support on Quality of Life by EORTC QLQ-C30 in Allogeneic Hematopoietic Stem Cell Transplantation. 
 Blood cell therapy      [Volume]5 [Issue]4 [Page]107 -115  (2022/)   [Reviewed] Yes  
[DOI] [3]. Final analysis of randomized phase II study optimizing melphalan, prednisolone, bortezomib in multiple myeloma (JCOG1105). 
 Cancer science      [Volume]113 [Issue]9 [Page]3267 -3270  (2022/)   [Reviewed] Yes  
[DOI] [4]. 【血液疾患における抗体医薬と免疫細胞療法の新たな展開】多発性骨髄腫に対するCAR-T細胞療法の現状と開発動向 
 血液内科   (有)科学評論社   [Volume]85 [Issue]1 [Page]47 -53  (2022/)   [Reviewed] No   
[Repository][5]. 乾癬様皮疹を呈した慢性移植片対宿主病の1例 
 日本皮膚科学会雑誌   (公社)日本皮膚科学会   [Volume]132 [Issue]8 [Page]1885   (2022/)   [Reviewed] Yes